PhotoniCare Invested 2017

Based in Raleigh, NC, in the Research Triangle, PhotoniCare was founded out of a shared passion to make a real impact on the health of children, starting with middle ear infections. With $10 billion spent annually to manage ear infections, and a documented 50% misdiagnosis rate for primary care physicians using otoscopes, PhotoniCare has developed a medical device that makes the middle ear visible to physicians and parents, thus enabling more accurate diagnose and appropriate care. The FDA-approved OtoSight Middle Ear Scope is the only technology capable of visualizing through the eardrum to assess middle ear fluid directly and non-invasively. Mass commercialization is anticipated for 2022.

Current tools used to diagnose fluid in the middle ear can be difficult to use reliably in squirming or crying children and rely heavily on user expertise to interpret a simple image or measurement of the eardrum. Designed to eliminate subjectivity and speculation, the simple-to-use OtoSight Middle Ear Scope has more than 90% reader accuracy in determining the presence or absence of fluid in the middle ear. PhotoniCare has secured temporary CPT codes while continuing to work on permanent CPT codes to ensure reimbursement.